_20240917103739_original_image_23.webp)
The rising demand for effective hair loss treatments has sparked growing interest in Exosome Therapy, particularly the use of plant-based exosomes. These nano-sized vesicles, vital to cell communication and tissue regeneration, are revolutionising hair restoration by stimulating dormant hair follicles. As this therapy gains momentum, a crucial debate has emerged regarding the safety and efficacy of plant-based exosomes compared to their animal-derived counterparts.
At a recent ‘HairTalks’ session, hosted by Global Cosmetic Surgery, experts explored the potential risks and benefits associated with different exosome sources. Plant-based exosomes, in particular, have been highlighted for their biocompatibility and safer profile, compared to animal-derived exosomes, which carry risks such as immunogenic reactions and potential zoonotic pathogen transmission.
Dr. Jane Yoo, a leading dermatologist from New York City, emphasised the transformative potential of Exosome Therapy. "Exosomes are at the cutting edge of hair restoration science, offering a promising pathway to rejuvenate hair follicles at a cellular level," said Dr. Yoo. She further stressed that the source of exosomes is crucial, “Plant-based exosomes show great promise due to their safety profile, whereas animal-derived exosomes present challenges such as immunogenicity and the risk of zoonotic diseases,” she added.
One major concern discussed was the teratogenic potential of animal-derived exosomes, which could lead to severe side effects, including birth defects. Dr. Kalpana Sarangi urged for stringent regulatory oversight and adherence to Good Manufacturing Practices (GMP) to mitigate these risks. On the other hand, plant-based exosomes were seen as a safer alternative, free from such potential complications.
As the popularity of hair restoration treatments rises, plant-based exosomes are being recognised for their lower risk of triggering immune responses and their safer profile. Experts at ‘HairTalks’ called for further research and regulatory guidelines to ensure the safe application of these therapies in clinical settings.
Dr. Vaibhav Kumar, Senior Manager at QR678, highlighted the significant advantages of plant-based exosomes. "Plant-based exosomes offer a safer alternative with reduced immunogenicity and avoid contamination risks typically associated with animal-derived options," he said. He also mentioned that his team is preparing to launch a next-generation exosome formula combined with growth factors and has applied for global patents for the same.
Complementing this discussion was the introduction of QR678, a patented treatment developed by Indian scientists. This treatment, which involves the administration of growth factors into the scalp, has shown promising results in treating various forms of hair loss, positioning it as a strong complement to Exosome Therapy.
Dr. Michael Gold, a renowned dermatologist and chief moderator at the event, expressed his excitement about these developments. "Exosome Therapy represents a major leap forward in hair restoration. Combining this with other treatments like QR678 could lead to more effective and personalised solutions for hair loss."
